1 year return (CAGR)
-86.78%
Actuate Therapeutics, Inc. Common stock Exchange (NASDAQ, USD)
ACTU
0.68
-0.07 (-7.51%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
21.79M
Price/Sales
-
Ent value
21.57M
Price/Book
22.03
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.99 |
| Daily high | 1.02 |
| Daily low | 0.89 |
| Daily Volume | 268K |
| All-time high | 11.90 |
| 1y analyst estimate | 11.68 |
| Beta | 0.78 |
| EPS (TTM) | -0.86 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 31 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ACTU | S&P500 | |
| Current price drop from All-time high | -94.29% | -0.84% |
| Highest price drop | -92.38% | -56.47% |
| Date of highest drop | 21 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -44.11% | -10.68% |
| Avg time to new high | 75 days | 12 days |
| Max time to new high | 329 days | 1805 days |
News
